Biotechnology | Disease | FDA | Therapeutics
FDA Approves Drug to Treat Lesions Caused by Herpes Simplex Virus
On Oct. 9, 2026, the U.S. Food and Drug Administration (FDA) has approved Asahi Kasei Therapeutics’ Hovilpri (pritelivir)…
On Oct. 9, 2026, the U.S. Food and Drug Administration (FDA) has approved Asahi Kasei Therapeutics’ Hovilpri (pritelivir)…
On Aug. 5, 2026, researchers at Dell Medical School at The University of Texas at Austin in collaboration…
On Jul. 14, 2025, researchers at MIT and other institutions announced they had identified compounds that can fight…
On May 15, 2024, researchers at Brazil’s Federal University of São Paulo announced they had found ancient herpes…